A detailed history of Founders Financial Securities LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Founders Financial Securities LLC holds 4,564 shares of ABBV stock, worth $757,441. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,564
Previous 4,871 6.3%
Holding current value
$757,441
Previous $754,000 10.21%
% of portfolio
0.09%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$159.82 - $182.1 $49,064 - $55,904
-307 Reduced 6.3%
4,564 $831,000
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $117,372 - $132,189
853 Added 21.23%
4,871 $754,000
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $48,359 - $55,983
362 Added 9.9%
4,018 $598,000
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $32,729 - $40,730
247 Added 7.25%
3,656 $492,000
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $18,943 - $21,816
-131 Reduced 3.7%
3,409 $543,000
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $49,376 - $59,215
-357 Reduced 9.16%
3,540 $572,000
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $43,484 - $49,873
324 Added 9.07%
3,897 $523,000
Q2 2022

Jul 27, 2022

SELL
$137.62 - $174.96 $3,715 - $4,723
-27 Reduced 0.75%
3,573 $547,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $7,786 - $9,661
59 Added 1.67%
3,600 $584,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $5,801 - $7,340
-54 Reduced 1.5%
3,541 $479,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $18,194 - $20,653
171 Added 4.99%
3,595 $388,000
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $5,786 - $6,446
55 Added 1.63%
3,424 $386,000
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $73,553 - $80,973
-719 Reduced 17.59%
3,369 $365,000
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $131,601 - $177,675
1,635 Added 66.65%
4,088 $438,000
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $222,936 - $261,653
-2,595 Reduced 51.41%
2,453 $215,000
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $370,371 - $495,612
5,048 New
5,048 $490,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Founders Financial Securities LLC Portfolio

Follow Founders Financial Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Securities LLC with notifications on news.